Upgrades:
Duke Energy (DUK) has a market capitalization of $27.27Billion. The company was upgraded by the brokerage firm “FBR Capital” from “Underperform” to ”Mkt Perform”. The stock price closed at $20.86 and has changed by 1.81% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 14.85, Price/Sales 1.87 and Price/Book 1.20. The earnings per share is expected to grow by 1.42% for next year and 3.93% for the upcoming 5 years.
1-Year Chart Of Duke Energy (Click to enlarge) |
Flow (FLOW) has a market capitalization of $2.95Billion. The company was upgraded by the brokerage firm “Northland Securities” from “Market Perform” to ”Outperform ($4)”. The stock price closed at $30.19 and has changed by 1.51% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 42.49, Price/Sales 1.65 and Price/Book 0.86. The earnings per share is expected to grow by 240.15% for next year and 9.67% for the upcoming 5 years.
1-Year Chart Of Flow (Click to enlarge) |
Validus Holdings (VR) has a market capitalization of $967.97Million. The company was upgraded by the brokerage firm “Stifel Nicolaus” from “Hold” to ”Buy ($38)”. The stock price closed at $4.42 and has changed by 5.24% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is -, Price/Sales 0.34 and Price/Book 0.43. The earnings per share is expected to grow by 46.34% for next year and 0.00% for the upcoming 5 years.
1-Year Chart Of Validus Holdings (Click to enlarge) |
MEMC Elec (WFR) has a market capitalization of $115.48Million. The company was upgraded by the brokerage firm “Collins Stewart” from “Neutral” to ”Buy ($5.5)”. The stock price closed at $3.52 and has changed by 45.45% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 48.40, Price/Sales 0.50 and Price/Book 1.44. The earnings per share is expected to grow by 122.22% for next year and 21.67% for the upcoming 5 years.
1-Year Chart Of MEMC Elec (Click to enlarge) |
Downgrades:
Invesco Mortgage Capital (IVR) has a market capitalization of $1.82Billion. The company was downgraded by the brokerage firm “FBR Capital” from “Outperform” to ”Mkt Perform ($16)”. The stock price closed at $14.71 and has changed by -6.54% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 4.20, Price/Sales 4.95 and Price/Book 0.96. The earnings per share is expected to grow by -7.52% for next year and 4.13% for the upcoming 5 years.
1-Year Chart Of Invesco Mortgage Capital (Click to enlarge) |
Invesco Mortgage Capital (IVR) has a market capitalization of $1.82Billion. The company was downgraded by the brokerage firm “JMP Securities” from “Mkt Outperform” to ”Mkt Perform”. The stock price closed at $14.71 and has changed by -6.54% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 4.20, Price/Sales 4.95 and Price/Book 0.96. The earnings per share is expected to grow by -7.52% for next year and 4.13% for the upcoming 5 years.
1-Year Chart Of Invesco Mortgage Capital (Click to enlarge) |
Pharmacyclics (PCYC) has a market capitalization of $1.00Billion. The company was downgraded by the brokerage firm “Global Hunter Securities” from “Buy” to ”Neutral ($15)”. The stock price closed at $12.39 and has changed by -15.25% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is -, Price/Sales 159.17 and Price/Book 10.67. The earnings per share is expected to grow by -42.90% for next year and 10.00% for the upcoming 5 years.
1-Year Chart Of Pharmacyclics (Click to enlarge) |
Pharmacyclics (PCYC) has a market capitalization of $1.00Billion. The company was downgraded by the brokerage firm “RBC Capital Mkts” from “Outperform” to ”Sector Perform ($15)”. The stock price closed at $12.39 and has changed by -15.25% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is -, Price/Sales 159.17 and Price/Book 10.67. The earnings per share is expected to grow by -42.90% for next year and 10.00% for the upcoming 5 years.
1-Year Chart Of Pharmacyclics (Click to enlarge) |
T. Rowe Price (TROW) has a market capitalization of $14.40Billion. The company was downgraded by the brokerage firm “Stifel Nicolaus” from “Buy” to ”Hold”. The stock price closed at $57.96 and has changed by 1.70% compared to the previous day.
Here are the price ratios of the company: The P/E ratio is 19.58, Price/Sales 5.28 and Price/Book 4.41. The earnings per share is expected to grow by 6.25% for next year and 12.79% for the upcoming 5 years.
1-Year Chart Of T. Rowe Price (Click to enlarge) |